Veradigm Inc.

$4.75+0.00%(+$0.00)
TickerSpark Score
59/100
Mixed
100
Valuation
40
Profitability
25
Growth
68
Health
60
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDRX research report →

52-Week Range58% of range
Low $3.00
Current $4.75
High $6.00

Companyveradigm.com

Veradigm Inc. , a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform.

CEO
Donald D. Trigg
IPO
1999
Employees
2,450
HQ
Chicago, IL, US

Price Chart

+7.95% · this period
$5.25$4.72$4.20May 20Nov 18May 20

Valuation

Market Cap
$806.69M
P/E
-7.08
P/S
1.37
P/B
0.60
EV/EBITDA
9.92
Div Yield
0.00%

Profitability

Gross Margin
52.45%
Op Margin
-4.61%
Net Margin
-14.70%
ROE
-7.13%
ROIC
-0.66%

Growth & Income

Revenue
$588.02M · 1.83%
Net Income
$-86,462,000 · -164.31%
EPS
$-0.67 · -165.05%
Op Income
$-27,103,000
FCF YoY
206.10%

Performance & Tape

52W High
$6.00
52W Low
$3.00
50D MA
$4.78
200D MA
$4.67
Beta
0.52
Avg Volume
266.10K

Get TickerSpark's AI analysis on MDRX

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 10, 26Jacobson Eric Lother1,584
May 1, 26Jacobson Eric Lother75,000
Apr 1, 26Syed Tehsin Mother220,986
Apr 1, 26Baker Tallyother110,493
Apr 1, 26Trigg Donaldother552,465
Nov 3, 25Baker Tallyother105,999
Nov 3, 25Syed Tehsin Mother423,998
Nov 3, 25Baker Tallyother0
Nov 3, 25Syed Tehsin Mother0
Sep 2, 25Trigg Donaldother571,428

Our MDRX Coverage

We haven't published any research on MDRX yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate MDRX Report →

Similar Companies